171 related articles for article (PubMed ID: 22549171)
1. Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts.
Kaunitz AM
Menopause; 2012 Jun; 19(6):602-3. PubMed ID: 22549171
[No Abstract] [Full Text] [Related]
2. Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms.
Canonico M; Scarabin PY
Menopause; 2011 Oct; 18(10):1038-9. PubMed ID: 21946050
[No Abstract] [Full Text] [Related]
3. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
[TBL] [Abstract][Full Text] [Related]
4. Patch instead of pill: a safer menopausal estrogen?
Cushman M
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):136-7. PubMed ID: 20089948
[No Abstract] [Full Text] [Related]
5. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Canonico M
Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
[TBL] [Abstract][Full Text] [Related]
6. Hormone therapy and hemostasis among postmenopausal women: a review.
Canonico M
Menopause; 2014 Jul; 21(7):753-62. PubMed ID: 24937030
[TBL] [Abstract][Full Text] [Related]
7. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis.
Scarabin PY
Climacteric; 2018 Aug; 21(4):341-345. PubMed ID: 29570359
[TBL] [Abstract][Full Text] [Related]
8. [Hormone replacement therapy and venous thromboembolism].
Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
Archer DF; Oger E
Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
[TBL] [Abstract][Full Text] [Related]
10. ACOG committee opinion no. 556: Postmenopausal estrogen therapy: route of administration and risk of venous thromboembolism.
Obstet Gynecol; 2013 Apr; 121(4):887-890. PubMed ID: 23635705
[TBL] [Abstract][Full Text] [Related]
11. Hormones and venous thromboembolism among postmenopausal women.
Scarabin PY
Climacteric; 2014 Dec; 17 Suppl 2():34-7. PubMed ID: 25223916
[TBL] [Abstract][Full Text] [Related]
12. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
Lacut K; Oger E
Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
[TBL] [Abstract][Full Text] [Related]
13. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
14. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Canonico M; Scarabin PY
Climacteric; 2009; 12 Suppl 1():76-80. PubMed ID: 19811247
[TBL] [Abstract][Full Text] [Related]
15. Hormone therapy and venous thromboembolism among postmenopausal women.
Scarabin PY
Front Horm Res; 2014; 43():21-32. PubMed ID: 24943295
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
[TBL] [Abstract][Full Text] [Related]
17. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.
Laliberté F; Dea K; Duh MS; Kahler KH; Rolli M; Lefebvre P
Menopause; 2011 Oct; 18(10):1052-9. PubMed ID: 21775912
[TBL] [Abstract][Full Text] [Related]
18. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
[TBL] [Abstract][Full Text] [Related]
19. Type of hormone replacement therapy and risk of venous thromboembolism.
Roberts H
BMJ; 2008 May; 336(7655):1203-4. PubMed ID: 18495630
[TBL] [Abstract][Full Text] [Related]
20. Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen.
Canonico M; Alhenc-Gelas M; Plu-Bureau G; Olié V; Scarabin PY
Menopause; 2010; 17(6):1122-7. PubMed ID: 20613675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
